| PDF Pages<\/th>\n | PDF Title<\/th>\n<\/tr>\n | ||||||
|---|---|---|---|---|---|---|---|
| 196<\/td>\n | undefined <\/td>\n<\/tr>\n | ||||||
| 201<\/td>\n | Foreword <\/td>\n<\/tr>\n | ||||||
| 202<\/td>\n | Introduction <\/td>\n<\/tr>\n | ||||||
| 205<\/td>\n | 1 Scope 2 Normative references 3 Terms and definitions 4 Symbols and abbreviated terms <\/td>\n<\/tr>\n | ||||||
| 207<\/td>\n | 5 Nanomaterials: Description and manufacturing 5.1 Manufactured nanomaterials <\/td>\n<\/tr>\n | ||||||
| 209<\/td>\n | 5.2 Production processes 5.2.1 Typical production processes 5.2.2 Aerosol generation methods 5.2.3 Vapor deposition methods 5.2.4 Colloidal\/self-assembly methods <\/td>\n<\/tr>\n | ||||||
| 210<\/td>\n | 5.2.5 Electrodeposition 5.2.6 Electrospinning 5.2.7 Attrition methods 6 Hazard characterization 6.1 Health effects 6.1.1 General <\/td>\n<\/tr>\n | ||||||
| 211<\/td>\n | 6.1.2 Basic principles and uncertainties <\/td>\n<\/tr>\n | ||||||
| 212<\/td>\n | 6.1.3 Potential relevance of health effects information about incidental or naturally-occurring NOAAs 6.1.4 Relationship between toxicity and surface area, surface chemistry, and particle number <\/td>\n<\/tr>\n | ||||||
| 213<\/td>\n | 6.1.5 Inflammatory response to NOAAs 6.1.6 Observations from epidemiological studies involving fine and nanoscale particles <\/td>\n<\/tr>\n | ||||||
| 214<\/td>\n | 6.2 Physical hazards 6.2.1 Fire (exothermic events) 6.2.2 Safety consideration in manufacturing NOAAs 7 Exposure assessment to nanomaterials 7.1 General <\/td>\n<\/tr>\n | ||||||
| 216<\/td>\n | 7.2 Scientific framework for assessing exposure to nanomaterials 7.2.1 Routes of exposure <\/td>\n<\/tr>\n | ||||||
| 218<\/td>\n | 7.2.2 Metric for assessing exposure to airborne nanomaterials <\/td>\n<\/tr>\n | ||||||
| 221<\/td>\n | 7.3 \u200bReview of methods for characterizing exposure to manufactured NOAAs 7.3.1 General <\/td>\n<\/tr>\n | ||||||
| 224<\/td>\n | 7.3.2 Sampling strategy issues <\/td>\n<\/tr>\n | ||||||
| 228<\/td>\n | 7.4 Dustiness assessment 7.4.1 General 7.4.2 Measurement methods <\/td>\n<\/tr>\n | ||||||
| 229<\/td>\n | 7.5 Dermal exposure assessment 7.5.1 Sampling <\/td>\n<\/tr>\n | ||||||
| 230<\/td>\n | 7.5.2 Sample characterization 7.6 Dose (internal exposure) assessment 7.7 Discussion <\/td>\n<\/tr>\n | ||||||
| 231<\/td>\n | 7.8 Summary 8 Risk assessment in occupational settings 8.1 Introduction and scope <\/td>\n<\/tr>\n | ||||||
| 232<\/td>\n | 8.2 Risk assessment for NOAAs 8.2.1 General 8.2.2 Quantitative and qualitative risk assessment <\/td>\n<\/tr>\n | ||||||
| 233<\/td>\n | 8.2.3 Hazard identification 8.2.4 Exposure-response assessment <\/td>\n<\/tr>\n | ||||||
| 235<\/td>\n | 8.2.5 Exposure assessment <\/td>\n<\/tr>\n | ||||||
| 236<\/td>\n | 8.2.6 Risk characterization 8.3 Conclusions 9 Risk mitigation approaches 9.1 Introduction <\/td>\n<\/tr>\n | ||||||
| 237<\/td>\n | 9.2 Implication of risk assessment in regard to control methodologies 9.2.1 Background <\/td>\n<\/tr>\n | ||||||
| 238<\/td>\n | 9.2.2 Strategies for control <\/td>\n<\/tr>\n | ||||||
| 239<\/td>\n | 9.3 Examination of control methodologies 9.3.1 Exposure prevention <\/td>\n<\/tr>\n | ||||||
| 240<\/td>\n | 9.3.2 Control strategies 9.3.3 Reducing risk through effective design <\/td>\n<\/tr>\n | ||||||
| 241<\/td>\n | 9.3.4 Substitution of raw materials, products, processes and equipment 9.3.5 Engineering control techniques <\/td>\n<\/tr>\n | ||||||
| 248<\/td>\n | 9.3.6 Administrative means for the control of workplace exposures <\/td>\n<\/tr>\n | ||||||
| 253<\/td>\n | 9.3.7 Evaluating the work environment <\/td>\n<\/tr>\n | ||||||
| 254<\/td>\n | 9.3.8 Personal protective equipment (PPE) <\/td>\n<\/tr>\n | ||||||
| 259<\/td>\n | 9.4 Health surveillance <\/td>\n<\/tr>\n | ||||||
| 260<\/td>\n | 9.5 Product stewardship <\/td>\n<\/tr>\n | ||||||
| 262<\/td>\n | Annex A (informative) Primary chemical composition of nanomaterials <\/td>\n<\/tr>\n | ||||||
| 270<\/td>\n | Annex B (informative) Nanomaterial-specific animal and cell culture toxicity studies <\/td>\n<\/tr>\n | ||||||
| 282<\/td>\n | Annex C (informative) Characteristics of selected instruments and techniques for monitoring nano-aerosol exposure <\/td>\n<\/tr>\n | ||||||
| 291<\/td>\n | Annex D (informative) Characteristics of biosafety cabinets <\/td>\n<\/tr>\n | ||||||
| 293<\/td>\n | Annex E (informative) Assigned protection factors for respirators <\/td>\n<\/tr>\n | ||||||
| 294<\/td>\n | Annex F (informative) Advantages and disadvantages of different types of air-purifying particulate respirators <\/td>\n<\/tr>\n | ||||||
| 297<\/td>\n | Bibliography <\/td>\n<\/tr>\n<\/table>\n","protected":false},"excerpt":{"rendered":" Tracked Changes. Nanotechnologies. Health and safety practices in occupational settings<\/b><\/p>\n |